Drug Target Identification in Tissues by Thermal Proteome Profiling
- 6 January 2022
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 62 (1), 465-482
- https://doi.org/10.1146/annurev-pharmtox-052120-013205
Abstract
Drug target deconvolution can accelerate the drug discovery process by identifying a drug's targets (facilitating medicinal chemistry efforts) and off-targets (anticipating toxicity effects or adverse drug reactions). Multiple mass spectrometry–based approaches have been developed for this purpose, but thermal proteome profiling (TPP) remains to date the only one that does not require compound modification and can be used to identify intracellular targets in living cells. TPP is based on the principle that the thermal stability of a protein can be affected by its interactions. Recent developments of this approach have expanded its applications beyond drugs and cell cultures to studying protein-drug interactions and biological phenomena in tissues. These developments open up the possibility of studying drug treatment or mechanisms of disease in a holistic fashion, which can result in the design of better drugs and lead to a better understanding of fundamental biology. Expected final online publication date for the Annual Review of Pharmacology and Toxicology, Volume 62 is January 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.Keywords
This publication has 113 references indexed in Scilit:
- Orbitrap Mass SpectrometryAnalytical Chemistry, 2013
- Direct identification of ligand-receptor interactions on living cells and tissuesNature Biotechnology, 2012
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survivalDrug Discovery Today, 2012
- Target Identification Using Drug Affinity Responsive Target Stability (DARTS)Current Protocols in Chemical Biology, 2011
- A Proteome-wide, Quantitative Survey of In Vivo Ubiquitylation Sites Reveals Widespread Regulatory RolesMolecular & Cellular Proteomics, 2011
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesNature Biotechnology, 2011
- Quantitative proteomics approach for identifying protein–drug interactions in complex mixtures using protein stability measurementsProceedings of the National Academy of Sciences of the United States of America, 2010
- Identification of a Primary Target of Thalidomide TeratogenicityScience, 2010
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular FunctionsScience, 2009
- Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsNature Biotechnology, 2007